Browsing by Author "b1f0eaaa-db68-4810-be54-73f2d8c7f29a"
Now showing items 1-4 of 4
-
Zerbini, Cristiano A. F.; Radominski, Sebastiao; Cardiel, Mario H.; Castaneda, Oswaldo; Romero, Felix; Citera, Gustavo; Neira Quiroga, Oscar; Ponce de León, Dario; Hoffman, Elaine; Rojo, Ricardo (Lippicott Williams & Wilkins, 2016-04)
-
Zerbini, Cristiano A. F.; Radominski, Sergio C; Cardiel, Mario; Castaneda, Oswaldo; Citera, Gustavo; Neira Quiroga, Oscar; Ponce de León, Dario; Hoffman, Elaine; Rojo, Ricardo (Lippicott Williams & Wilkins, 2016-04)
-
Pons Estel, Guillermo; Ugarte Gil, Manuel; Harvey, Guillermina; Wojdyla, Daniel; Quintana, Rosana; Serrano Morales, Rosa; Gómez Puerta, José; García, Mercedes; Catoggio, Luis; Saurit, Verónica; Drenkard, Cristina; Da Silva, Nilzio Antonio; Cavalcanti, Fernando; Borba, Eduardo; Sato, Emilia; Neira Quiroga, Óscar; Massardo, Loreto; Vásquez, Gloria; Alonso González, Luis; Guibert Toledan, Marlene; Silveira, Luis; García de la Torre, Ignacio; Sauza del Pozo, María Josefina; Chacón, Rosa; Cardiel, Mario; Alarcón, Graciela S.; Pons-Estel, Bernardo A. (Wiley, 2020)
-
Radominski, Sebastiao; Cardiel, Mario; Citera, Gustavo; Goecke Sariego, Irmgadt; Jaller, Juan José; Vannucci Lomonte, Andrea Barranjard; Miranda, Pedro; Vélez, Patricia; Xibille, Daniel; Kwok, Kenneth; Rojo, Ricardo; García, Erika Gabriela (Elsevier, 2017)Objective: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We assessed tofacitinib efficacy and safety in the Latin American (LA) subpopulation of global Phase 3 and long-term ...